Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Abercrombie & Fitch
ANF
$4.84B
| $15.3M | 0.01% |
961,959
+296,083
| +44% | +$5.72M |
|
1202
PUT
Chubb
CB
$132B
| $15.3M | 0.01% |
121,600
+88,100
| +263% | +$11.2M |
|
1203
CALL
PACCAR
PCAR
$68B
| $15.3M | 0.01% |
389,850
-11,700
| -3% | -$445K |
|
|
VA
1204
PUT
DELISTED
Virgin America Inc.
VA
| $15.3M | 0.01% |
285,400
+194,900
| +215% | +$10.9M |
|
1205
HSBC
HSBC
$358B
| $15.3M | 0.01% |
+449,429
| New | +$14.1M |
|
1206
CALL
Synaptics
SYNA
$3.71B
| $15.3M | 0.01% |
260,400
+90,000
| +53% | +$4.95M |
|
1207
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
| $15.2M | 0.01% |
53,939
-51,284
| -49% | -$14.4M |
|
1208
CALL
Invesco
IVZ
$14.4B
| $15.2M | 0.01% |
486,300
+142,800
| +42% | +$4.2M |
|
|
MJN
1209
DELISTED
Mead Johnson Nutrition Company
MJN
| $15.2M | 0.01% |
192,446
+105,549
| +121% | +$9M |
|
1210
PUT
Vanguard FTSE Europe ETF
VGK
$31.3B
| $15.2M | 0.01% |
311,600
-466,000
| -60% | -$22.4M |
|
1211
CALL
Arista Networks
ANET
$241B
| $15.1M | 0.01% |
2,848,000
-1,560,000
| -35% | -$7.43M |
|
1212
PUT
Alnylam Pharmaceuticals
ALNY
$32.1B
| $15.1M | 0.01% |
223,200
+64,400
| +41% | +$4.54M |
|
1213
PUT
Eastman Chemical
EMN
$8.23B
| $15.1M | 0.01% |
222,600
-260,200
| -54% | -$17.5M |
|
1214
PUT
American Water Works
AWK
$27.3B
| $15.1M | 0.01% |
201,300
+163,600
| +434% | +$12.8M |
|
1215
PUT
Ryder
R
$9.44B
| $15.1M | 0.01% |
228,200
-2,900
| -1% | -$190K |
|
|
SPWR
1216
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $15M | 0.01% |
2,575,744
+1,231,831
| +92% | +$9.57M |
|
1217
CALL
BioMarin Pharmaceuticals
BMRN
$12.8B
| $15M | 0.01% |
162,100
-121,700
| -43% | -$11.5M |
|
1218
CALL
iShares Russell 1000 ETF
IWB
$48.9B
| $15M | 0.01% |
124,300
+96,600
| +349% | +$11.6M |
|
|
WLL
1219
PUT
DELISTED
Whiting Petroleum Corporation
WLL
| $14.9M | 0.01% |
5,701
+1,713
| +43% | +$4.02M |
|
1220
CALL
Bunge Global
BG
$21.5B
| $14.9M | 0.01% |
252,300
-3,900
| -2% | -$242K |
|
1221
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $14.9M | 0.01% |
624,000
-859,200
| -58% | -$20.7M |
|
1222
PUT
Welltower
WELL
$174B
| $14.9M | 0.01% |
198,700
+54,100
| +37% | +$4.14M |
|
1223
PUT
Infosys
INFY
$48.7B
| $14.8M | 0.01% |
1,875,400
+968,800
| +107% | +$7.98M |
|
|
RDUS
1224
CALL
DELISTED
Radius Health, Inc.
RDUS
| $14.7M | 0.01% |
272,400
+184,800
| +211% | +$9.39M |
|
1225
CALL
AerCap
AER
$23.2B
| $14.7M | 0.01% |
382,500
+116,300
| +44% | +$4.39M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.